374 related articles for article (PubMed ID: 12771010)
1. Enalapril decreases the incidence of atrial fibrillation in patients with left ventricular dysfunction: insight from the Studies Of Left Ventricular Dysfunction (SOLVD) trials.
Vermes E; Tardif JC; Bourassa MG; Racine N; Levesque S; White M; Guerra PG; Ducharme A
Circulation; 2003 Jun; 107(23):2926-31. PubMed ID: 12771010
[TBL] [Abstract][Full Text] [Related]
2. Enalapril treatment and hospitalization with atrial tachyarrhythmias in patients with left ventricular dysfunction.
Alsheikh-Ali AA; Wang PJ; Rand W; Konstam MA; Homoud MK; Link MS; Estes NA; Salem DN; Al-Ahmad AM
Am Heart J; 2004 Jun; 147(6):1061-5. PubMed ID: 15199356
[TBL] [Abstract][Full Text] [Related]
3. Quantification of the risk and predictors of hyperkalemia in patients with left ventricular dysfunction: a retrospective analysis of the Studies of Left Ventricular Dysfunction (SOLVD) trials.
de Denus S; Tardif JC; White M; Bourassa MG; Racine N; Levesque S; Ducharme A
Am Heart J; 2006 Oct; 152(4):705-12. PubMed ID: 16996842
[TBL] [Abstract][Full Text] [Related]
4. Atrial fibrillation and heart failure in cardiology practice: reciprocal impact and combined management from the perspective of atrial fibrillation: results of the Euro Heart Survey on atrial fibrillation.
Nieuwlaat R; Eurlings LW; Cleland JG; Cobbe SM; Vardas PE; Capucci A; López-Sendòn JL; Meeder JG; Pinto YM; Crijns HJ
J Am Coll Cardiol; 2009 May; 53(18):1690-8. PubMed ID: 19406345
[TBL] [Abstract][Full Text] [Related]
5. Drug Insight: angiotensin-converting-enzyme inhibitors and atrial fibrillation--indications and contraindications.
Lévy S
Nat Clin Pract Cardiovasc Med; 2006 Apr; 3(4):220-5. PubMed ID: 16568131
[TBL] [Abstract][Full Text] [Related]
6. Ventricular proarrhythmic effects of atrial fibrillation are modulated by depolarization and repolarization anomalies in patients with left ventricular dysfunction.
Lemola K; Khan R; Nattel S; Talajic M; Roy D; Guerra PG; Lemola S; Dubuc M; Thibault B; Macle L; Khairy P
Pacing Clin Electrophysiol; 2009 Jan; 32(1):99-105. PubMed ID: 19140919
[TBL] [Abstract][Full Text] [Related]
7. Incidence of atrial fibrillation in relation to changing heart rate over time in hypertensive patients: the LIFE study.
Okin PM; Wachtell K; Kjeldsen SE; Julius S; Lindholm LH; Dahlöf B; Hille DA; Nieminen MS; Edelman JM; Devereux RB
Circ Arrhythm Electrophysiol; 2008 Dec; 1(5):337-43. PubMed ID: 19808428
[TBL] [Abstract][Full Text] [Related]
8. Angiotensin-converting enzyme inhibitor as a risk factor for the development of anemia, and the impact of incident anemia on mortality in patients with left ventricular dysfunction.
Ishani A; Weinhandl E; Zhao Z; Gilbertson DT; Collins AJ; Yusuf S; Herzog CA
J Am Coll Cardiol; 2005 Feb; 45(3):391-9. PubMed ID: 15680718
[TBL] [Abstract][Full Text] [Related]
9. Economic impact of the reduced incidence of atrial fibrillation in patients with heart failure treated with enalapril.
Wagner M; Rindress D; Desjardins B; Meilleur MC; Ducharme A; Tardif JC
Am Heart J; 2005 Nov; 150(5):985. PubMed ID: 16290980
[TBL] [Abstract][Full Text] [Related]
10. The relevance of subgroup-specific treatment effects: the Studies Of Left Ventricular Dysfunction (SOLVD) revisited.
Parker AB; Yusuf S; Naylor CD
Am Heart J; 2002 Dec; 144(6):941-7. PubMed ID: 12486418
[TBL] [Abstract][Full Text] [Related]
11. Impact of ramipril on the incidence of atrial fibrillation: results of the Heart Outcomes Prevention Evaluation study.
Salehian O; Healey J; Stambler B; Alnemer K; Almerri K; Grover J; Bata I; Mann J; Matthew J; Pogue J; Yusuf S; Dagenais G; Lonn E;
Am Heart J; 2007 Sep; 154(3):448-53. PubMed ID: 17719288
[TBL] [Abstract][Full Text] [Related]
12. Atrial fibrillation and morbidity and mortality in a cohort of long-term hemodialysis patients.
Genovesi S; Vincenti A; Rossi E; Pogliani D; Acquistapace I; Stella A; Valsecchi MG
Am J Kidney Dis; 2008 Feb; 51(2):255-62. PubMed ID: 18215703
[TBL] [Abstract][Full Text] [Related]
13. Persistent atrial fibrillation is associated with appropriate shocks and heart failure in patients with left ventricular dysfunction treated with an implantable cardioverter defibrillator.
Rienstra M; Smit MD; Nieuwland W; Tan ES; Wiesfeld AC; Anthonio RL; Van den Berg MP; Van Veldhuisen DJ; Van Gelder IC
Am Heart J; 2007 Jan; 153(1):120-6. PubMed ID: 17174649
[TBL] [Abstract][Full Text] [Related]
14. Prevalence, pathophysiology, and clinical significance of post-heart transplant atrial fibrillation and atrial flutter.
Ahmari SA; Bunch TJ; Chandra A; Chandra V; Ujino K; Daly RC; Kushwaha SS; Edwards BS; Maalouf YF; Seward JB; McGregor CG; Chandrasekaran K
J Heart Lung Transplant; 2006 Jan; 25(1):53-60. PubMed ID: 16399531
[TBL] [Abstract][Full Text] [Related]
15. Left ventricular systolic dysfunction and atrial fibrillation in older people in the community--a need for screening?
Ho SF; O'Mahony MS; Steward JA; Burr ML; Buchalter M
Age Ageing; 2004 Sep; 33(5):488-92. PubMed ID: 15271642
[TBL] [Abstract][Full Text] [Related]
16. Adverse effect of ventricular pacing on heart failure and atrial fibrillation among patients with normal baseline QRS duration in a clinical trial of pacemaker therapy for sinus node dysfunction.
Sweeney MO; Hellkamp AS; Ellenbogen KA; Greenspon AJ; Freedman RA; Lee KL; Lamas GA;
Circulation; 2003 Jun; 107(23):2932-7. PubMed ID: 12782566
[TBL] [Abstract][Full Text] [Related]
17. Angiotensin converting enzyme inhibitor and angiotensin receptor blockade use in relation to outcomes in anticoagulated patients with atrial fibrillation.
Lip GY; Frison L; Grind M
J Intern Med; 2007 Jun; 261(6):577-86. PubMed ID: 17547713
[TBL] [Abstract][Full Text] [Related]
18. Association between renin-angiotensin-aldosterone system blockers and postoperative atrial fibrillation in patients with mild and moderate left ventricular dysfunction.
Ozaydin M; Varol E; Türker Y; Peker O; Erdoğan D; Doğan A; Ibrişim E
Anadolu Kardiyol Derg; 2010 Apr; 10(2):137-42. PubMed ID: 20382613
[TBL] [Abstract][Full Text] [Related]
19. Efficacy of medical therapy for the reduction of heart failure events in patients with implanted cardioverter defibrillators.
Pietrasik G; Goldenberg I; McNitt S; Polonsky B; Moss AJ; Zareba W
J Cardiovasc Electrophysiol; 2009 Apr; 20(4):395-400. PubMed ID: 19017351
[TBL] [Abstract][Full Text] [Related]
20. Atrial fibrillation in recipients of cardiac resynchronization therapy device: 1-year results of the randomized MASCOT trial.
Padeletti L; Muto C; Maounis T; Schuchert A; Bongiorni MG; Frank R; Vesterlund T; Brachmann J; Vicentini A; Jauvert G; Tadeo G; Gras D; Lisi F; Dello Russo A; Rey JL; Boulogne E; Ricciardi G;
Am Heart J; 2008 Sep; 156(3):520-6. PubMed ID: 18760135
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
